Skip to main content
Log in

Optimum Treatment of Rhinitis in the Elderly

  • Practical Therapeutics
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

With aging, multiple physiological changes occur in the connective tissue and vasculature of the nose which may predispose or contribute to chronic rhinitis. Accurate differentiation of allergic from nonallergic causes of rhinitis requires skin testing or in vitro measures of specific IgE.

Empiric treatment with over-the-counter first generation antihistamines and oral decongestants frequently results in CNS, anticholinergic and cardiovascular adverse effects. While newer second generation histamine antagonists do not cause these problems, selected drugs in this class may cause electrocardiographic QT prolongation and, in rare cases, ventricular arrhythmias. Topical therapies including sodium cromoglycate (cromolyn sodium), corticosteroids and ipratropium bromide are all well-tolerated with minimal adverse effects.

Avoidance of allergens and/or irritants is an important adjunct in treating patients with allergic and vasomotor rhinitis. If all other therapies fail in patients with confirmed allergic rhinitis, immunotherapy can be safely instituted in most older patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Patterson CN. The aging nose: characteristics and correction. Otolarngol Clin North Am 1980; 13: 275–88

    CAS  Google Scholar 

  2. Hollander AR. Histopathology of the nasal mucosa of older persons. Arch Otorhinol 1944; 40: 92–100

    Google Scholar 

  3. Bende M. Blood flow with 132Xe in human nasal mucosa in relation to age, sex and body position. Acta Otorhinol 1983; 96: 175–9

    CAS  Google Scholar 

  4. Broder I, Higgins MW, Matthews KP, et al. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allergy Clin Immunol 1974; 53: 127–38

    Article  PubMed  CAS  Google Scholar 

  5. Drake-Lee AB, Lowe D, Swanston DL, et al. Clinical profile and recurrence of nasal polyps. J Laryngol Otol 1984; 98: 783–93

    Article  PubMed  CAS  Google Scholar 

  6. Moore GF, Freeman TJ, Ogren FP, et al. Extended follow-up of total inferior turbinate resection for relief of chronic nasal obstruction. Laryngoscope 1985; 95: 1095–9

    Article  PubMed  CAS  Google Scholar 

  7. Meltzer EO. Comparative safety of H1 antihistamines. Ann Allergy 1991; 67: 625–33

    PubMed  CAS  Google Scholar 

  8. Simons KJ, Watson WTA, Chen WY, et al. Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly. Clin Pharmacol Ther 1989; 45: 9–14

    Article  PubMed  CAS  Google Scholar 

  9. Simons KJ, Martin TJ, Watson WTA, et al. Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly. J Allergy Clin Immunol 1990; 85: 540–7

    Article  PubMed  CAS  Google Scholar 

  10. Simons KJ, Watson WTA, Martin TJ, et al. Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults and children. J Clin Pharmacol 1990; 30: 665–71

    PubMed  CAS  Google Scholar 

  11. Woosley RL, Chen YY, Freiman JP, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993; 269: 1532–6

    Article  PubMed  CAS  Google Scholar 

  12. Craft TM. Torsade de Pointes after astemizole overdose. BMJ 1986; 292: 660–1

    Article  PubMed  CAS  Google Scholar 

  13. Hilbert J, Moritzen V, Parks A, et al. The pharmacokinetics of loratadine in normal geriatric volunteers. J Int Med Res 1988; 16: 59–61

    Google Scholar 

  14. Matzke GR, Yeh J, Awni WM, et al. Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Ann Allergy 1987; 59 (Pt 2): 25–30

    PubMed  CAS  Google Scholar 

  15. Lake CR, Gallant S, Masson E, et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990; 89: 195–208

    Article  PubMed  CAS  Google Scholar 

  16. Beck RA, Mercado DL, Seguin SM, et al. Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients. Arch Intern Med 1992; 152: 1242–5

    Article  PubMed  CAS  Google Scholar 

  17. Kroenke K, Omori DM, Simmons JO, et al. The safety of phenylpropanolamine in patients with stable hypertension. Ann Intern Med 1989; 111: 1043–4

    PubMed  CAS  Google Scholar 

  18. Juniper EF, Guyatt GH, Archer B, et al. Aqueous beclometha sone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of ‘as needed’ use. J Allergy Clin Immunol 1993; 92 (1 Pt 1): 66–72

    Article  PubMed  CAS  Google Scholar 

  19. Milford CA, Mugliston TA, Lund VJ, et al. Long term safety and efficacy study of ipatropium bromide. J Laryngol Otol 1990; 104: 123–5

    Article  PubMed  CAS  Google Scholar 

  20. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988; 43: 523–9

    Article  PubMed  CAS  Google Scholar 

  21. Matloff SM, Bailit IW, Parks P, et al. Systemic reactions to immunotherapy. Allergy Proc 1993; 14: 347–450

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, R., Corren, J. Optimum Treatment of Rhinitis in the Elderly. Drugs & Aging 7, 168–175 (1995). https://doi.org/10.2165/00002512-199507030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199507030-00002

Keywords

Navigation